FDA
-
-
-
-
-
-
-
Asieris: CEVIRA Approved in China as First-in-Class Non-Invasive Therapy for Cervical Precancerous Lesions
-
-
-
-
-
-
-
Bladder Cancer technology: New improved Blue Light Cystoscopy system receives FDA approval for use in NMIBC in the U.S.
-
-
-
-
-
-
328,607 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

